“inflammation” Archives

Entry Author Date Location
Landos Joins Garabedian’s Bio Startup Accelerator Xontogeny, Gets $10M 09/21/17 Boston
Celgene Broadens Forma Deal, Adding $195M More for Drug R&D 08/29/17 New York
FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price 03/28/17 New York
Corbus Shares Climb on Early Data For Inflammation Drug 11/14/16 Boston
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
Houston’s Fannin Forms Company to Fight Inflammation-Induced Cancers 09/21/15 Texas
Celgene to Acquire San Diego’s Receptos for $7.2B in Cash 07/14/15 San Diego
Second Genome Has Begun First Drug Trial Based on Microbiome Secrets 01/12/15 San Francisco
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target 01/03/13 San Diego
SD Biotech Roundup: Life Technologies, KFx Medical, Shire, & More 06/15/12 San Diego
What Are the Hottest Targets in Biotech Today? 04/23/12 National
San Diego’s InflammaGen Advances Therapy to Mitigate Effects of Shock 03/12/12 San Diego
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine 12/23/11 San Diego
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai 03/10/11 Boston
San Diego’s Leading Ventures Takes on Commercialization of Bioengineering Breakthroughs 02/08/11 San Diego
Xoma Nabs $35M Upfront Deal 01/04/11 San Francisco
Anthera, On a Lean Budget, Seeks to Tap Big Heart Attack Market By Blocking Inflammation 11/16/10 San Francisco
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
Alder Reduces Anemia in Cancer Study 06/06/10 Seattle
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
How Internet Pioneer Larry Smarr Lost 20 Pounds by Becoming a “Quantified Self” 05/12/10 San Diego
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
Genzyme Expects to Pay $175M to FDA, Westphal Leaves Sirtris to Run GSK Venture Arm, Gelesis Obesity Treatment Passes First Human Trial, & More Boston-Area Life Sciences News 04/23/10 Boston
Catabasis, Led by Sirtris Vets, Seeks to Fight Diabetes by Controlling Inflammation 04/21/10 Boston
Ascent Changes to Anchor 03/30/10 Boston
Flexion Snags Pfizer Bucks, Three Pharma Deals, For New Drug Model 01/29/10 Boston
Omeros Moves Closer To IPO, Sets Price Goal 09/16/09 Seattle
Page 1 of 2 next page »